Davis Polk advised the sole placing agent for the primary placement of an aggregate of 78,000,000 new shares in Innovent Biologics, Inc. for a total consideration of approximately HK$2.4…
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Dexin China Holdings Company Limited of $200 million 11.875% senior notes due 2022.
Dexin China…
Davis Polk advised the initial purchasers in connection with a $150 million Regulation S only offering by China South City Holdings Limited of its 11.5% senior notes due 2022.
CSC is a…
Davis Polk advised the joint lead managers in connection with the Regulation S only offering by Gaoxin International Investment Co., Ltd. of its $100 million 6.00% guaranteed bonds due 2022…
Davis Polk advised the placing agents for the top-up placement of up to 97,000,000 shares in Innovent Biologics, Inc. for a total consideration of approximately HK$2.4 billion.
Davis Polk…
Davis Polk advised the initial purchasers in connection with a debut Regulation S offering by Zensun Enterprises Limited of $220 million 12.8% senior notes due 2021. The notes are…
Davis Polk is advising China Yongda Automobiles Services Holdings Limited in connection with its proposed acquisition of the entire issued shares of Inchcape Asia Pacific Limited from a…
Davis Polk advised the arrangers in connection with the establishment of the $2.5 billion medium-term note programme of DFZQ (the “Programme”).
Davis Polk also advised the joint lead…
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $152 million principal amount of 12.5% senior notes due 2021 by Yango (Cayman) Investment Limited…
Davis Polk advised the initial purchasers in connection with a $400 million debut Regulation S offering by Shuifa International Holdings (BVI) Co., Ltd of its 4.15% guaranteed bonds due…